Federal Supply Schedule 36F79719D0194
Award Date
7/15/19
Last Date to Order
2/1/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Paratek Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule (FSS) contract 36F79718D0461 was awarded to Prime Contractor Para Pro LLC, a small disadvantaged business and veteran-owned manufacturer of goods, to provide pharmaceuticals and related hematology products. The contract has a $250,000 ceiling value and a performance period ending on May 31, 2025. This multiple award FSS contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and was awarded by the Department of Veterans Affairs, Veterans...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Metuchen Pharmaceuticals LLC. The contract is for Pharmaceuticals and Drugs (FSS-61-IB) and has a ceiling value of $6,800,000 with a period of performance through February 14, 2025. The contract aims to procure a variety of pharmaceutical and hematology-related products for the VA's Veterans Integrated Service Network 12. As an FSS contract, it allows for the VA and other federal agencies to...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to H2-Pharma LLC, a for-profit limited liability company, to provide pharmaceuticals and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, is a multiple award vehicle that allows federal agencies to procure the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Tetraphase Pharmaceuticals Inc., a for-profit organization and subsidiary of La Jolla Pharmaceutical Company. The contract is for the procurement of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract is a multiple-award, unrestricted (no set-aside) vehicle with...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned, small disadvantaged business. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and enables the VA to procure a wide range of pharmaceutical and hematology-related products from the vendor. The $2,225,000 multiple-award contract has a period of performance through June 14, 2026. As a Federal Supply Schedule contract, it...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Apotex Corp., provides for the delivery of 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products. The contract has a ceiling value of $23,375,390.00 and a period of performance running from September 15, 2024 through September 14, 2029. As a Federal Supply Schedule (FSS) contract, this is a multiple award vehicle that allows federal agencies to procure the specified pharmaceutical and related...
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to provide drugs, pharmaceuticals, and hematology-related products to VHA facilities. The prime contractor is Nabriva Therapeutics US Inc., a for-profit organization. The contract has a potential value of $225,000 and a period of performance through October 15, 2023. No set-asides were used in the...
The Federal Supply Schedule (FSS) contract 36F79720D0139 was awarded by the Veterans Integrated Service Network (VISN) 12, a division of the Department of Veterans Affairs (VA), to Pd-Rx Pharmaceuticals, Inc. This is a multiple-award IDV contract valued at $18.4 million, effective from June 1, 2020 to May 31, 2026. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule, enabling Pd-Rx Pharmaceuticals to supply drugs, pharmaceuticals, and hematology-related products to...
The Federal Supply Schedule (FSS) contract 36F79720D0115 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Secura Bio, Inc., a for-profit manufacturer, on April 1, 2020. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule and has a ceiling value of $250,000.00. It is a multiple award contract with no set-asides, and the period of performance runs through September 30, 2025. The purpose of the contract is to provide drugs,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...